Mateusz Kaczmarek, Author at TechStock²

Dow Falls as Palantir Plunges – Is the AI Stock Boom Turning into a Bubble?

Diverging Markets: Tech Strength vs. Blue-Chip Weakness Stock trading to kick off November has been a tale of two markets. High-tech and growth stocks are extending their momentum, while old-line blue chips struggle. On Monday (Nov. 3), the benchmark S&P

4 November 2025

Artificial Intelligence·Dow Jones·Investment Analysis·Market Trends·Stock Market

Hertz Stock Skyrockets on First Profit in 2 Years – What It Means for Investors

Hertz’s Q3 2025 Comeback: First Profit in Years Fuels Rally Cars parked near a Hertz rental location at New York’s JFK Airport (symbolizing recovering demand). Hertz stunned investors with a return to profitability in Q3 2025, marking a pivotal milestone

4 November 2025

Company Earnings·Financial News·Investing·Stock Market

Dave Inc. (DAVE) Stock – Fintech Underdog Turned Wall Street Rocket

Current Stock Price & Recent Performance Dave Inc.’s stock has been on a tear in 2025. Shares currently trade around $264 as of November 4, 2025, after spiking nearly 10% on the morning of its earnings release Stockanalysis. This jump

4 November 2025

Company Analysis·Fintech·Investing·Stocks·Wall Street

Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Company Profile & Background Scienture Holdings, Inc. is a tiny specialty pharmaceutical company focused on developing and commercializing novel formulations that address unmet needs in healthcare Globenewswire Globenewswire. The company’s roots trace back to a 2024 merger with TRxADE Health,

4 November 2025

Company Analysis·Financial News·Investment Insights·Pharma Industry·Stock Market

Prelude Therapeutics (PRLD) Stock’s Wild Ride: 150% Surge, Big Pharma Deal & What’s Next

A Wild Week for PRLD Stock Prelude Therapeutics – a small precision oncology biotech – suddenly became one of the market’s most volatile stocks in early November 2025. On Monday, Nov 3, PRLD shares skyrocketed, at one point gaining over

4 November 2025

Biotech·Company Analysis·Investing·Pharma News·Stock Market

Ondas Holdings (ONDS) Stock Skyrockets 770% – Huge Deals, Price Swings & 2025 Outlook

Current Stock Price & Recent Performance Chart: ONDS daily closing price, Sep–Nov 2025. After a meteoric rise in early October, the stock has retraced to the mid-$6 range. Ondas Holdings’ stock has experienced a roller coaster ride in recent weeks.

4 November 2025

Financial Analysis·Investing·Market News·Stocks

Cipher Mining (CIFR) Rockets on AI Mega-Deals & Bitcoin Boom – What Investors Need to Know

Recent News Highlights (Early November 2025) Cipher Mining has made headlines this week with a flurry of major developments: Company Overview & Business Model Cipher Mining Inc. is a U.S.-based technology company that builds and operates industrial-scale data centers for

4 November 2025

Artificial Intelligence·Bitcoin·Cryptocurrency·Investing·Stock Market

Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Company Overview & History Kenvue Inc. is a leading consumer health company formed from Johnson & Johnson’s storied consumer products division. The name “Kenvue” combines “ken” (knowledge) and “vue” (view), reflecting a vision of insight-driven care Wikipedia. As a spin-off,

4 November 2025

Financial Analysis·Investment Strategies·Mergers & Acquisitions·Pharmaceutical Industry·Stock Market News

Bitfarms (BITF) 2025 Stock Surge: Bitcoin Miner’s $500M Windfall & AI Pivot Fuel Rally

Bottom Line: Bitfarms has rapidly transformed in 2025 from a struggling miner into a well-capitalized player at the forefront of both Bitcoin mining and emerging AI infrastructure. The stock’s dramatic rise mirrors the company’s improved prospects, but future performance will

4 November 2025

AI Technology·Cryptocurrency·Investment Trends·Stock Market

Nvidia’s $5 Trillion Milestone: AI Boom Propels NVDA Stock to New Heights

NVDA Stock Skyrockets on AI Frenzy Nvidia’s stock has been on a meteoric rise, fueled by an unprecedented boom in artificial intelligence. As of November 4, 2025, NVDA trades around $207 per share, up roughly 70–80% year-to-date Indiatimes Indiatimes. The

4 November 2025

Artificial Intelligence·Investing·NVIDIA·Stock Market·Technology News

Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Stock Price and Recent Performance Year-to-date chart of Evoke Pharma (EVOK) stock through early November 2025. Shares were volatile throughout 2025, and the Q4 acquisition announcement (right end of chart) triggered a dramatic spike to new highs, bringing the stock

4 November 2025

Financial Analysis·Investment News·Mergers & Acquisitions·Pharma Industry·Stock Market

Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Company Overview & 2025 Developments Zoetis is the global frontrunner in animal health, offering a diverse portfolio for both companion animals (pets) and farm animals. The company’s products range from vaccines and parasiticides to dermatology treatments and high-tech diagnostics. This

4 November 2025

Biotechnology·Investment Insights·Pharmaceutical Industry·Stock Analysis